According to the global catheter-directed thrombolysis devices market report by IMARC Group, the market reached a value of US$ 356.7 Million in 2022, and it is projected to reach a value of US$ 489.0 Million by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.
Thrombosis is the occurrence of a blood clot within a blood vessel, obstructing blood flow in either an artery or vein. Catheter-directed thrombolysis (CDT) devices remove or dissolve these clots and restore proper blood circulation. These devices deliver anticoagulant drugs directly to the clot site to improve blood flow and prevent damage to tissues and organs. They commonly include an x-ray camera, a catheter, radiographic tables, one or two x-ray tubes, and a monitor for visualizing the procedure. At present, additional equipment such as ultrasound machines and heart rate and blood pressure monitors are also used to facilitate the process.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/catheter-directed-thrombolysis-devices-market/requestsample
Catheter-Directed Thrombolysis Device Market Trends and Drivers:
The global catheter-directed thrombolysis devices market is primarily driven by the increasing incidences of chronic diseases, such as heart disorders, cancer, obesity, and kidney problems. Moreover, the rising consumer awareness about the benefits of the early detection and treatment of pulmonary embolism and deep vein thrombosis is positively influencing the market growth.
Additionally, numerous advancements in CDT devices for reducing the risk of post-thrombotic syndrome and improving patient care are other major growth-inducing factors. Besides this, the surging adoption of minimally invasive surgery as a safer alternative to conventional open surgery is contributing to market growth.
Furthermore, the development of pharmacomechanical CDT (PCDT) techniques that reduce treatment time and healthcare costs has catalyzed market growth. Other factors, including the aging population, rising government investments in healthcare, and inflating consumer disposable incomes, are also anticipated to create a positive market outlook.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/catheter-directed-thrombolysis-devices-market
Global Catheter-Directed Thrombolysis Devices Market 2023-2028 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Catheter-Directed Thrombolysis Devices Companies:
AngioDynamics, Inc., Boston Scientific Corporation, Inari Medical, Inc., iVascular, S.L.U, Medtronic Plc, Penumbra, Inc., Straub Medical AG (Becton, Dickinson and Company), Teleflex Incorporated, Thrombolex Inc. etc.
The report has segmented the market on the basis of region, delivery mode, indication and end user.
Breakup by Delivery Mode:
- Directly Delivery to Blood Clot
- Positioning Medical Device at Clot Site
Breakup by Indication:
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
Breakup by End User:
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
134 N 4th St.
Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800